JB/CALL/PFIZER INC/38/0.1/20.12.24 Stock

Warrant

PFXGJB

CH1276772063

Market Closed - Swiss Exchange 11:20:00 2024-05-22 am EDT
0.03 ^CHF	+30.43%

1 month	+30.43%
3 months	-40.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart PFIZER, INC.

Chart JB/CALL/PFIZER INC/38/0.1/20.12.24

Latest news about PFIZER, INC.

Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates	May. 30	AQ
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	May. 30	AQ
Pfizer : Showcases New Data Across its Broadened Oncology Portfolio at ASCO Annual Meeting	May. 29	PU
BioNTech gets $145 mln funding for African vaccine plants	May. 29	RE

More news

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	PFIZER, INC.
Issuer	Bank Julius Bär
	PFXGJB
ISIN	CH1276772063
Date issued	2023-06-28
Strike	38 $
Maturity	2024-12-20 (204 Days)
Parity	10 : 1
Emission price	0.36 CHF
Emission volume	N/A
Settlement	cash
Currency	CHF

Technical Indicators

Highest since issue	0.39 CHF
Lowest since issue	0.021 CHF
Spread	0.01 CHF
Spread %	33.33%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sector

More about the company